BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2606455)

  • 1. Immunohistochemistry and lectin histochemistry in sarcomatoid renal cell carcinoma: a comparison with classical renal cell carcinoma.
    Harris SC; Hird PM; Shortland JR
    Histopathology; 1989 Dec; 15(6):607-16. PubMed ID: 2606455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomatoid chromophobe cell renal carcinoma: immunohistochemical and lectin study in one case.
    Gómez-Román JJ; Mayorga-Fernández M; Fernández-Fernández F; Val-Bernal JF
    Gen Diagn Pathol; 1997 Jul; 143(1):63-9. PubMed ID: 9269910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms.
    Attanoos RL; Dojcinov SD; Webb R; Gibbs AR
    Histopathology; 2000 Sep; 37(3):224-31. PubMed ID: 10971698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases.
    DeLong W; Grignon DJ; Eberwein P; Shum DT; Wyatt JK
    Arch Pathol Lab Med; 1993 Jun; 117(6):636-40. PubMed ID: 7684893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcomatoid conversion of clear cell renal cell carcinoma in relation to epithelial-to-mesenchymal transition.
    Boström AK; Möller C; Nilsson E; Elfving P; Axelson H; Johansson ME
    Hum Pathol; 2012 May; 43(5):708-19. PubMed ID: 21992819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomatoid renal cell carcinoma: the chromophobe connection.
    Akhtar M; Tulbah A; Kardar AH; Ali MA
    Am J Surg Pathol; 1997 Oct; 21(10):1188-95. PubMed ID: 9331291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomatoid collecting duct carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Baer SC; Ro JY; Ordonez NG; Maiese RL; Loose JH; Grignon DG; Ayala AG
    Hum Pathol; 1993 Sep; 24(9):1017-22. PubMed ID: 7504649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological features and prognosis of renal cell carcinoma with sarcomatoid differentiation].
    Jiang Y; Su G; Yu W; Li J; Lu Q; Li Y; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):823-6. PubMed ID: 26887511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of Fas and Fas ligand in sarcomatoid renal cell carcinoma.
    Leroy X; Wacrenier A; De la Taille A; Gosset P; Saint F; Biserte J; Gosselin B
    APMIS; 2001 Jun; 109(6):469-73. PubMed ID: 11506480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epithelial markers in sarcomatoid carcinoma: an immunohistochemical study.
    Ogawa K; Kim YC; Nakashima Y; Yamabe H; Takeda T; Hamashima Y
    Histopathology; 1987 May; 11(5):511-22. PubMed ID: 2440792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
    Yu W; Wang Y; Jiang Y; Zhang W; Li Y
    BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD10 immunoreactivity in sarcomatoid carcinomas: comparison with true sarcomas.
    Vennapusa B; Fischer EG; Wick MR; Cerilli LA
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):408-12. PubMed ID: 21908981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.
    Tickoo SK; Alden D; Olgac S; Fine SW; Russo P; Kondagunta GV; Motzer RJ; Reuter VE
    J Urol; 2007 Apr; 177(4):1258-63. PubMed ID: 17382701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on morphological and immunophenotypic features of renal cell carcinoma with sarcomatoid differentiation].
    Xiao L; Lu XY; Tang RY; Deng M; Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):259-60. PubMed ID: 17706118
    [No Abstract]   [Full Text] [Related]  

  • 15. Sarcomatoid carcinoma of urinary bladder: immunohistochemical study of an uncommon case.
    Cappello F; Aragona F; Serretta V; Randazzo G; Melloni D
    Urol Int; 2002; 69(2):141-4. PubMed ID: 12187046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
    Chang A; Brimo F; Montgomery EA; Epstein JI
    Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression.
    Delahunt B; Eble JN; Nacey JN; Grebe SK
    Anticancer Res; 1999; 19(5B):4279-83. PubMed ID: 10628387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of collagen expression in sarcomatoid renal cell carcinoma.
    Delahunt B; Bethwaite PB; McCredie MR; Nacey JN
    Hum Pathol; 2007 Sep; 38(9):1372-7. PubMed ID: 17521699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
    Ordóñez NG
    Hum Pathol; 2004 Jun; 35(6):697-710. PubMed ID: 15188136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.